Nurse practitioners (NPs) are registered nurses with additional education who demonstrate the competencies Canadian Nurse Practitioner Core Competency Framework (CNA, 2010) to independently diagnose, order, and interpret diagnostic tests, prescribe pharmaceuticals and perform clinical procedures. The NP scope of practice is defined by the activities and functions that NPs are educated and authorized to perform in accordance with the Registered Nurses Act (2008), Registered Nurses Regulations (2013), the Standards of Practice for Registered Nurses and Nurse Practitioners (2019) and organizational policy. ARNNL licenses NPs in one of the three NP streams of practice: NP-Adult; NP- Pediatric; NP-Family/All-Ages. NPs practice within their level of competence, stream of practice and practice setting.
In June 2013, ARNNL Council approved implementation of the New Classes of Practitioners Regulations (2012) in Newfoundland and Labrador. NPs having met the requirements established by Council are authorized to prescribe controlled drugs and substances in accordance with the Controlled Drugs and Substances Act and the New Classes of Practitioners Regulations (2012).
On October 20th, 2017, ARNNL Council approved a change in the scope of NP practice and designated Buprenorphine-Naloxone (Suboxone) and Methadone as drugs NPs, who meet the specified practice and education requirements, may prescribe for the treatment of opioid dependence or pain management as deemed appropriate for the specific client. NPs must complete ALL of the identified education and practice requirements to prescribe Buprenorphine-Naloxone (Suboxone) and Methadone.